Poland· PL-100456669
Argosulfan
A sulfathiazole product containing sulfathiazolum argentum, registered in Poland by Delfarma Sp. z o.o..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Sulfathiazolum argentum
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- D06BA02
- ATC class
- Sulfathiazole
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991462802
- gtin05909991462819
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under D06BA02
Sulfathiazole, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0c3e0024-ee30-4f32-9ef6-8328f3dd4172 GET /v1/drugs/0c3e0024-ee30-4f32-9ef6-8328f3dd4172?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krem",
"source": "urpl",
"strength": "20 mg/g",
"packaging": "05909991462802 ¦ Rp ¦ 141492\n1 tuba 40 g\n05909991462819 ¦ Rp ¦ 141493\n1 tuba 100 g",
"substance": "Sulfathiazolum argentum 20 mg/g",
"common_name": "Sulfathiazolum argentum",
"pl_product_id": "100456669",
"pozwolenie_nr": "304/21",
"auth_procedure": "IR",
"authorisation_validity": "2031-08-16"
}See everything about sulfathiazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.